The President & CEO of BioLife Solutions is Exercising Options


Yesterday it was reported that the President & CEO of BioLife Solutions (BLFS), Michael Rice, exercised options to sell 34,383 BLFS shares at $1.64 a share, for a total transaction value of $1.09M.

In addition to Michael Rice, 13 other BLFS executives reported Sell trades in the last month. Following Michael Rice’s last BLFS Sell transaction on October 01, 2020, the stock climbed by 1.8%.

See today’s analyst top recommended stocks >>

Based on BioLife Solutions’ latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $11.28 million and GAAP net loss of -$1,133,000. In comparison, last year the company earned revenue of $6.6 million and had a net profit of $10.27 million. The company has a one-year high of $35.74 and a one-year low of $7.37. Currently, BioLife Solutions has an average volume of 304.36K.

Based on 7 analyst ratings, the analyst consensus is Strong Buy with an average price target of $37.25, reflecting a -15.7% downside.

The insider sentiment on BioLife Solutions has been negative according to 79 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts